Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5

Glycoconjugate vaccines based on isolated capsular polysaccharide (CPS) save millions of lives annually by preventing invasive pneumococcal disease caused by Streptococcus pneumoniae. Some components of the S. pneumoniae glycoconjugate vaccine Prevnar13 that contains CPS antigens from 13 serotypes u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Proc Natl Acad Sci U S A
Autores principales: Lisboa, Marilda P., Khan, Naeem, Martin, Christopher, Xu, Fei-Fei, Reppe, Katrin, Geissner, Andreas, Govindan, Subramanian, Witzenrath, Martin, Pereira, Claney L., Seeberger, Peter H.
Formato: Artigo
Lenguaje:Inglês
Publicado: National Academy of Sciences 2017
Materias:
Physical Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651752/
https://ncbi.nlm.nih.gov/pubmed/28973947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1706875114
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares